INC Research Holdings Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $42.74
- Today's High:
- $42.79
- Open Price:
- $42.78
- 52W Low:
- $22.894
- 52W High:
- $55.16
- Prev. Close:
- $42.76
- Volume:
- 741582
Company Statistics
- Market Cap.:
- $4.43 billion
- Book Value:
- 33.686
- Revenue TTM:
- $5.42 billion
- Operating Margin TTM:
- 6.33%
- Gross Profit TTM:
- $1.25 billion
- Profit Margin:
- 1.31%
- Return on Assets TTM:
- 2.63%
- Return on Equity TTM:
- 2.09%
Company Profile
INC Research Holdings Inc had its IPO on 2014-11-07 under the ticker symbol SYNH.
The company operates in the Healthcare sector and Diagnostics & Research industry. INC Research Holdings Inc has a staff strength of 28,768 employees.
Stock update
Shares of INC Research Holdings Inc opened at $42.78 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $42.74 - $42.79, and closed at $42.74.
This is a -0.05% slip from the previous day's closing price.
A total volume of 741,582 shares were traded at the close of the day’s session.
In the last one week, shares of INC Research Holdings Inc have increased by +0.05%.
INC Research Holdings Inc's Key Ratios
INC Research Holdings Inc has a market cap of $4.43 billion, indicating a price to book ratio of 1.0744 and a price to sales ratio of 0.6553.
In the last 12-months INC Research Holdings Inc’s revenue was $5.42 billion with a gross profit of $1.25 billion and an EBITDA of $587.48 million. The EBITDA ratio measures INC Research Holdings Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, INC Research Holdings Inc’s operating margin was 6.33% while its return on assets stood at 2.63% with a return of equity of 2.09%.
In Q2, INC Research Holdings Inc’s quarterly earnings growth was a negative -99% while revenue growth was a positive 0.4%.
INC Research Holdings Inc’s PE and PEG Ratio
- Forward PE
- 8.0128
- Trailing PE
- 61.0286
- PEG
- 1.2799
Its diluted EPS in the last 12-months stands at $0.7 per share while it has a forward price to earnings multiple of 8.0128 and a PEG multiple of 1.2799. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into INC Research Holdings Inc’s profitability.
INC Research Holdings Inc stock is trading at a EV to sales ratio of 1.1991 and a EV to EBITDA ratio of 9.1076. Its price to sales ratio in the trailing 12-months stood at 0.6553.
INC Research Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $8.08 billion
- Total Liabilities
- $1.63 billion
- Operating Cash Flow
- $-18905000.00
- Capital Expenditure
- $17.96 million
- Dividend Payout Ratio
- 0%
INC Research Holdings Inc ended 2024 with $8.08 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $8.08 billion while shareholder equity stood at $3.49 billion.
INC Research Holdings Inc ended 2024 with $69.34 million in deferred long-term liabilities, $1.63 billion in other current liabilities, 1037000.00 in common stock, $96.34 million in retained earnings and $4.91 billion in goodwill. Its cash balance stood at $82.17 million and cash and short-term investments were $82.17 million. The company’s total short-term debt was $68,274,000 while long-term debt stood at $2.64 billion.
INC Research Holdings Inc’s total current assets stands at $1.95 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.70 billion compared to accounts payable of $137.02 million and inventory worth $109000.00.
In 2024, INC Research Holdings Inc's operating cash flow was $-18905000.00 while its capital expenditure stood at $17.96 million.
Comparatively, INC Research Holdings Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $42.74
- 52-Week High
- $55.16
- 52-Week Low
- $22.894
- Analyst Target Price
- $42.5
INC Research Holdings Inc stock is currently trading at $42.74 per share. It touched a 52-week high of $55.16 and a 52-week low of $55.16. Analysts tracking the stock have a 12-month average target price of $42.5.
Its 50-day moving average was $42.48 and 200-day moving average was $38.94 The short ratio stood at 5.59 indicating a short percent outstanding of 0%.
Around 48.5% of the company’s stock are held by insiders while 9474.5% are held by institutions.
Frequently Asked Questions About INC Research Holdings Inc
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.